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ABSTRACT Competition studies between cholesterol and ergosterol were carried out to gain insight into the binding
interactions between nystatin and these sterols. Lipid vesicles were prepared with mixtures of palmitoyloleoylphosphocholine/
ergosterol/cholesterol, and both sterol molar ratio and total content were varied. The inhibitory effect of cholesterol toward the
ergosterol ability to induce the formation of long-lived ﬂuorescent antibiotic species was used to detect nystatin-cholesterol
interactions. It was found that the key factor controlling nystatin photophysical properties in the ternary lipid mixtures was their
ergosterol/cholesterol molar ratio and not their overall sterol content. Moreover, permeabilization studies showed that nystatin
was able to form pores in all the mixed vesicles, but the initial rate of pore formation was also dependent on the ergosterol/
cholesterol molar ratio. Our data show that ergosterol is displaced by competing cholesterol, indirectly conﬁrming cholesterol’s
ability to coassemble with nystatin. The distinct spectroscopic properties emphasize the different molecular architecture
adopted by nystatin-cholesterol and -ergosterol complexes, and therefore are relevant to understanding the interaction of the
antibiotic with membranes.
INTRODUCTION
Polyene antibiotics, including nystatin (Nys) and amphoter-
icin B (AmB), are clinically important as potent antifungal
agents. The biological target for their action is the plasma
membrane of the antibiotic-sensitive organisms, where they
are believed to exert their function through the formation of
barrel-like membrane-spanning ion channels. The preferen-
tial interaction of these antibiotics with fungal as compared
to mammalian cells has often been correlated with their rela-
tively higher afﬁnity for ergosterol (Erg) than for cholesterol
(Chol), respectively (1,2). However, the role of sterols in
polyene antibiotics mechanism of action remains poorly
understood. In an effort to characterize the species formed in
each case, different spectroscopic techniques have been em-
ployed previously to measure changes undergone by these
polyene antibiotics in the presence of sterols (1–3). Never-
theless, a direct demonstration that polyene antibiotics estab-
lish an interaction with sterols in lipid bilayers has been
elusive for a long time (4).
Recently, we have shown that both Chol and Erg are able
to promote the formation of Nys pores in the lipid bilayers
that lead to the dissipation of a potassium gradient, i.e., an
antibiotic active species. However, only in Erg/1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) but not in
Chol/POPC vesicles the absorption and ﬂuorescence prop-
erties of this polyene antibiotic varied signiﬁcantly with the
sterol content of the lipid vesicles. We proposed that the
molecular architecture of the active antibiotic species was
dependent upon the type of sterol included in the membrane,
and that the detected spectroscopic changes resulted from the
antibiotic-Erg aggregates being putatively more rigid and
stable than the Chol ones (5).
To further elucidate this question, and in an effort to
determine the relative afﬁnities of this antibiotic for Chol and
Erg, we carried out competition binding studies between the
two sterols and Nys by exploiting the sensitivity of its ﬂuo-
rescence properties to the aggregation state of the antibiotic.
It has been shown earlier that the antibiotic’s mean ﬂuo-
rescence lifetime is capable of tracking changes in Nys olig-
omerization state in the lipid bilayers, either resulting solely
from the self-association of the membrane-bound antibiotic
molecules in gel-phase lipid vesicles (6) or from the forma-
tion of Erg-antibiotic complexes (5). Our results show that
the Erg/Chol ratio and not the overall sterol content of the
three-component Erg/Chol/POPC vesicles was the key factor
controlling Erg’s ability in inducing the formation of long-
lived ﬂuorescent antibiotic species. Furthermore, Nys ability
to permeabilize the ternary lipid vesicles was also dependent
on the Erg/Chol molar ratio. This supports the view that Chol
and Erg compete for the binding of Nys, and that the pho-
tophysical properties and consequently the molecular struc-
ture of the channels formed are very different in each case.
MATERIALS AND METHODS
Materials
The polyene antibiotic Nys and Chol were obtained from Sigma (St.
Louis, MO). POPC and 1-palmitoyl-2-stearoyl(11,12)dibromo-sn-glycero-
3-phosphocholine (brPC) were purchased from Avanti Polar Lipids
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(St. Louis, MO). Erg was obtained from Fluka Chemika (St. Louis, MO);
1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-(4-trimethylammoniumphenyl)-
6-phenyl-1,3,5-hexatriene p-toluenesulfonate (TMA-DPH) were obtained
from Molecular Probes (Eugene, OR). All organic solvents were Uvasol
grade and were supplied by Merck (St. Louis, MO).
Lipid vesicles
Large unilamellar vesicles (LUV) (total lipid concentration;1.4 mM) were
prepared as described elsewhere (7). Brieﬂy, a lipid ﬁlm, after drying under
vacuum overnight, was hydrated with the desired buffer solution (20 mM
Hepes-NaOH (pH 7.4) with 150 mM NaCl and 1 mM EDTA) and vortex-
mixed to produce multilamellar vesicles (MLV). The suspension was
subjected to eight freeze-thaw cycles and then extruded through polycar-
bonate ﬁlters (400 and 100 nm pore size ﬁlter, four and 10 times, respec-
tively). The lipid concentration was determined in triplicate by phosphorus
analysis (8). Adequate volume of Nys stock solution (;1 mM in methanol)
was added by injection to the lipid vesicles. All the samples were allowed to
equilibrate for 30 min before the measurements.
Nystatin partitioning experiments
Partition coefﬁcients of Nys were determined by a centrifugation method
using brominated lipids (5,9). The total and free Nys concentrations were
assayed by absorption spectrophotometry using e304 ¼ 7.43 104 M1cm1
(10). The mol-fraction partition coefﬁcient, Kp, of Nys was calculated
according to Santos et al. (11).
Binary phase diagram determination
MLV (total lipid concentration 0.2 mM) of Erg/POPC binary mixtures were
prepared as described above. DPH was added at a probe to phospholipid
molar ratio of 1:200 before lipid ﬁlm formation. Steady-state ﬂuorescence
anisotropies (lexc ¼ 380 nm and lem ¼ 428 nm) were measured at different
temperatures in 10 3 4 mm quartz cuvettes. The data were analyzed as
described previously (12).
Nys activity assays
H1/K1 exchange assays across the membrane bilayer were carried out as
described previously to indirectly evaluate the effect of Nys on the potas-
sium permeability of the lipid vesicles (5). Brieﬂy, the decrease in the ﬂuo-
rescence intensity of the entrapped pH sensitive pyranine was used to follow
the acidiﬁcation of the intravesicular space of the liposomes prepared with a
variable lipid composition. The activity assays were started by submitting
the liposomes to a transmembrane K1 gradient of 3.3:1 [K1]in:[K
1]out. After
120 s, Nys (5–25 mM ﬁnal concentration) was added to the lipid suspension.
Total dissipation of the K1 gradient was obtained after the addition of the
ionophore valinomycin to the liposomes after 300 s.
All the data were analyzed according to the formalism described in
Coutinho et al. (5). The percentage of potassium gradient dissipation was
calculated from:
%K
1
dissipation ¼ pH
0
in  pH300in
pH
0
in  pHvalin
 
3100; (1)
where pHoin and pH
300
in are the pH inside the lipid vesicles at times t¼ 0 s and
t ¼ 300 s and pHvalin is the pH obtained after the addition of valinomycin.
The apparent initial rate of pore formation by Nys in the liposomes, vo,
was determined from the initial slope of the function p9(t), which is the appar-
ent average number of pores per lipid vesicle that had been formed from
t ¼ 0 to t (13–15):
p9ðtÞ ¼ 1nRðtÞ ¼ ln pHinðtÞ  pH
300
in
pH
0
in  pHvalin
 
; (2)
where R(t) is the retention function of the liposome population and pHin(t)
is the time course of the pH decrease of the inner vesicular space of
the liposomes, which is followed by the variation of ﬂuorescence intensity
of pyranine.
Absorption and ﬂuorescence measurements
Absorption spectra were measured at room temperature using a Jasco
(Easton, MD) V-560 spectrophotometer and corrected for light-scattering
artifacts by subtracting the respective blank sample. For steady-state ﬂuo-
rescence experiments an SLM-Aminco 8100 Series 2 spectroﬂuorometer
(Jobin Yvon, Edison, NJ), with double excitation and emission monochro-
mators and a 450 W xenon arc lamp was used. Nys ﬂuorescence
measurements were carried out in 0.5 3 0.5 cm quartz cuvettes using 320
and 410 nm as the excitation and emission wavelengths, respectively.
Typically, excitation and emission slits of 4 nm were used. All the data were
corrected for background intensities from antibiotic-free samples. Correction
of excitation and emission spectra was performed using the software
supplied by the manufacturer.
Steady-state ﬂuorescence anisotropy measurements of TMA-DPH
(lexc ¼ 355 nm and lem ¼ 428 nm) were carried out at a phospholipid molar
ratio of 1:100. The time-correlated single-photon timing method was used to
obtain the time-resolved ﬂuorescence data. The instrumentation used was
described in detail elsewhere (16). All the samples were excited at 320 nm
and the emission (at 410 nm) was detected at the magic-angle (54.7) relative
to the vertically polarized excitation beam. The decays were analyzed using
a sum of exponentials
I ðtÞ ¼ +
n
i¼1
ai expðt=tiÞ; (3)
where ai and ti are the normalized amplitude and lifetime of component i.
The mean ﬂuorescence lifetime was deﬁned as,
Ætæ ¼ +ait2i =+aiti: (4)
The adequacy of the multiexponential decay ﬁt was judged by the
reduced x2 value (values between 1.0 and 1.2 were accepted) with random
distribution of residuals and autocorrelation of residuals. For all the systems
four exponentials were always required to describe the ﬂuorescence decay of
Nys, in agreement with our previous studies (5).
RESULTS
Competition ﬂuorescence studies between
cholesterol and ergosterol for nystatin
The purpose of these experiments was to determine the
relative afﬁnity of the mammalian and fungal sterols, Chol
and Erg, respectively, for the polyene antibiotic Nys by taking
advantage of the sensitivity of its ﬂuorescence properties to
the oligomerization state of the membrane-bound antibiotic
molecules. The ﬁrst experiments were designed so that the
total sterol mol fraction included in the liposomes was kept
constant (10 mol % sterol), while the Erg/Chol molar ratio
(E/C) of the ternary lipid mixtures was varied. This con-
centration was chosen because above this onset Erg is no
longer the limiting reagent for mixed Erg-Nys complex
formation (5). Therefore, it was anticipated that the eventual
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competition between Chol and Erg for Nys binding should
be maximal below this value. In the presence of 10 mol %
Erg-containing POPC vesicles there was a pronounced increase
in Nys’s mean ﬂuorescence lifetime from ;5 to 38 ns upon
raising the overall antibiotic concentration (Fig. 1 A). The
substitution of only one-fourth of Erg by Chol, i.e., upon
preparing 7.5:2.5:90 Erg/Chol/POPC LUV, drastically re-
duced Nys’s ability to form long-lived ﬂuorescent antibiotic-
Erg aggregates in the lipid bilayer. Further replacement of
Erg by Chol, resulting in a ternary lipid mixture with an Erg/
Chol ratio of 1, completely abolished this effect. The mean
ﬂuorescence lifetime of the antibiotic now becomes inde-
pendent of its concentration, and is similar with the one
observed for Nys interacting with sterol-free POPC LUV. In
addition, the progressive substitution of Erg by Chol in the
lipid bilayers also eliminated the alterations undergone by
Nys ﬂuorescence spectra, namely the appearance of a strong
absorption at shorter wavelengths (;270–280 nm), concom-
itantly to the formation of the long-lived ﬂuorescent anti-
biotic species (Fig. 1 B). These results cannot be solely
ascribed to the reduction of the Erg content of the lipid
vesicles because Nys’s mean ﬂuorescence lifetime still
showed a reasonable increase with the antibiotic concentra-
tion used both in the presence of 5.0 and 7.5 mol % Erg-
containing POPC LUV, as it is shown in Fig. 1 A.
In a second set of experiments, the Erg content of the lipid
vesicles was held constant and increasing amounts of Chol
were added to the liposomes until reaching 30 mol % total
sterol. As shown in Fig. 2, A and B, where Erg content was
7.5 and 20 mol %, respectively, the supplementation of the
initial binary Erg/POPC mixtures with increasing amounts of
Chol caused again the progressive disappearance of the long-
lived ﬂuorescent antibiotic species formed by Nys in the
liposomes. The data further show that the key factor con-
trolling the extent of formation of long-lived ﬂuorescent
antibiotic oligomers was the Erg/Chol ratio, and not the total
sterol content (Fig. 2 C). For example, the addition of up to
25 mMNys to 7.5:22.5:70 Erg/Chol/POPC (E/C ¼ 1:3, open
squares, Fig. 2 A) liposomes did not produce any change in
the ﬂuorescence emission decay kinetics of the antibiotic.
However, when the same range of Nys concentrations inter-
acted with 20:10:70 Erg/Chol/POPC LUV (E/C ¼ 2:1, solid
squares, Fig. 2 B) a small proportion of slow decaying
ﬂuorescent antibiotic species could still be detected.
To check if Nys was able to permeabilize the membrane of
the different lipid vesicles driving the formation of pores that
lead to the total dissipation of the imposed K1 gradient, activ-
ity studies were carried out. It was observed that addition of
the antibiotic to the vesicles lead to a complete dissipation
of the gradient, independently of the sterol composition (Fig.
3 A). However, the initial rate of pore formation was again
highly dependent on the Erg/Chol molar ratio (Fig. 3, B
and C).
Physical properties of the lipid vesicles prepared
with a variable sterol composition
Altogether, the data above strongly suggest that the changes
undergone by Nys ﬂuorescence emission decay kinetics result
from speciﬁc interactions established between the antibiotic
and the two sterols—Erg and Chol—incorporated in the lipid
bilayers. However, changes in the bulk physical properties of
the lipid vesicles upon varying their sterol content and
composition could also indirectly contribute to this behavior,
e.g., by controlling Nys partitioning toward the liposomes,
and thus must also be explored.
To clarify this point, the ability of Chol and Erg in forcing
the phospholipid acyl chains to adopt a signiﬁcantly higher
molecular order in bilayers of POPC/sterol prepared with
high sterol content was ﬁrst compared. To this end, we
determined the partial binary phase diagram of POPC/Erg
lipid mixtures using DPH as a ﬂuorescent probe. The
ﬂuorescence emission anisotropy of DPH is very sensitive to
FIGURE 1 Effect of lipid vesicle composition on Nys spectroscopic
properties. (A) Mean ﬂuorescence lifetime, Ætæ, of nystatin in POPC LUV
containing (¤) 0 mol %, (n) 5 mol %, (:) 7.5 mol %, and (d) 10 mol %
ergosterol, or (n) 7.5:2.5 mol % Erg/Chol and (h) 5:5 mol % Erg/Chol,
respectively. (B) Normalized excitation (lem ¼ 410 nm) and emission (lexc ¼
320 nm) ﬂuorescence spectra of 20 mM nystatin in the presence of POPC
LUV with 10 mol % Erg (thick black line), 7.5:2.5 mol % Erg/Chol (thick
gray line), 5:5 mol % Erg/Chol (thin black line) and 10 mol % Chol (thin
gray line), respectively.
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both the molecular order and dynamics of the phospholipid
acyl chains (17), and its steady-state value can be used to
monitor the appearance of a liquid-ordered phase, lo, in the
lipid bilayers upon increasing their sterol mol fraction (12).
FIGURE 2 Ergosterol/cholesterol molar ratio determines Nys photo-
physical properties. Mean ﬂuorescence lifetime, Ætæ, of nystatin in POPC
LUV containing (A) (d) 7.5 mol % Erg, (s) 7.5:2.5 mol % Erg/Chol, (n)
7.5:7.5 mol % Erg/Chol, and (h) 7.5:22.5 mol % Erg/Chol, and (B) (d) 20
mol % Erg, (s) 20:5 mol % Erg/Chol, (n) 20:10 mol % Erg/Chol,
respectively. (C) Inﬂuence of the Erg/Chol molar ratio (E:C) present in the
lipid vesicles on the mean ﬂuorescence lifetime, Ætæ, of (h) 15 mM, (d)
20 mM, and (C) 25 mM nystatin, respectively.
FIGURE 3 Erg/Chol molar ratio determines Nys ability to permeabilize
lipid vesicles. (A) Percentage of transmembrane K1 gradient dissipated by
Nys 300 s after the beginning of each assay in POPC LUV containing (d) 10
mol % Erg, ()) 10 mol % Chol, and (h) 5:5 mol %, (3) 10:5 mol %, and
(s) 20:5 mol % Erg/Chol, respectively. (B) Apparent initial rate of pore
formation, vo, in POPC LUV containing (d) 10 mol % Erg, ()) 10 mol %
Chol, and (h) 5:5 mol %, (¤) 7.5:2.5 mol %, (3) 10:5 mol %, (s) 20:5 mol
%, and (:) 7.5:22.5 mol % Erg/Chol, respectively. (C) Inﬂuence of the
Erg/Chol molar ratio (E:C) present in the lipid vesicles on the initial rate of
pore formation, vo, of (h) 15 mM, (d) 20 mM, and (s) 25 mM nystatin,
respectively.
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The results obtained for Erg/POPC binary mixtures are
exempliﬁed in Fig. 4 A for T ¼ 37C. Upon increasing Erg
mol fraction, there was a progressive increase in the steady-
state ﬂuorescence emission anisotropy of DPH until ;40
mol % Erg was reached. The ld/lo phase boundaries of the
binary system were identiﬁed as the two breakpoints
detected in this plot at Xerg ¼ 13 mol % and Xerg ¼ 41 mol
%, respectively (Fig. 3 B, solid circles). The phase diagram
determined for POPC/Erg mixtures (Fig. 3 B, solid circles) is
similar to the one previously published for POPC/Chol (Fig.
4 B, open circles) (12), except that at temperatures higher
than 15C the transition to a pure lo phase occurs at a lower
Erg compared to Chol mol fractions. This suggests that Erg
is a more effective promoter of the lo phase in POPC than
Chol. It is interesting to note that Xu et al. (18) have also
found that Erg promotes the formation of raft-like domains
more strongly than Chol.
Secondly, we tested the possibility that the properties of the
interfacial region of the lipid bilayers could be varyingwith the
sterol content and Erg/Chol molar ratio used in the preparation
of the liposomes, and thus indirectly modulating Nys ﬂuores-
cence properties. Because the ﬁrst step of Nys interaction with
the lipid bilayers is expected to involve the adsorption of
monomeric antibiotic molecules to the polar head region of the
lipid membranes, we monitored the steady-state ﬂuorescence
emission anisotropy of TMA-DPH to explore this region of the
lipid bilayer. TMA-DPH is a derivative of DPHwith a cationic
moiety attached to the para-position of one of the phenyl rings
(19). Although DPH is known to be internalized into the
hydrophobic core of the membrane, the amphipathic TMA-
DPH is localized in the membrane bilayer with its positive
charge localized at the lipid-water interface (20). As shown in
Table 1, the steady-state ﬂuorescence emission anisotropy of
TMA-DPH was essentially independent of the Erg/Chol
molar ratio or the total sterol content of the binary and ternary
lipid mixtures studied, Æræ  0.22 6 0.01.
Nystatin partitioning toward lipid vesicles
prepared with a variable sterol composition
The previous result is in agreement with earlier ﬁndings
showing that the partitioning behavior of Nys was not
affected by the membrane sterol type nor content (0–30 mol
%), always presenting a mol-fraction partition coefﬁcient,
Kp 1.53 104 toward the binary sterol/POPC lipid mixtures
used (5). We further conﬁrmed here that the use of LUV
prepared with a three-component lipid mixture (Erg/Chol/
POPC) did not change the partitioning equilibrium of Nys
toward the LUV prepared (Table 1, Kp (1.46 0.2)3 104).
DISCUSSION
In this study, we addressed the question whether ﬂuores-
cence spectroscopy could be used to indirectly detect the
FIGURE 4 POPC/Erg binary phase diagram. (A) Determination of ld/lo
phase coexistence boundaries for the binary lipid mixture POPC/ergosterol
at 37C using the steady-state emission ﬂuorescence anisotropy of DPH, Æræ
(lexc ¼ 380 nm and lem ¼ 428 nm). The straight lines drawn through the
experimental points distinguish the three regimes: ld phase, ld 1 lo
coexistence, and lo phase for low, intermediate, and high ergosterol mol
fractions, respectively. The vertical dashed lines were drawn only to guide
the eye. (B) The partial binary phase diagram for POPC/ergosterol (d) was
obtained from the intersections between the lines drawn at each temperature.
The partial phase diagram previously obtained for POPC/cholesterol was
also plotted (s) (12).
TABLE 1 Inﬂuence of the lipid composition on the steady-state
ﬂuorescence emission anisotropy, hri, of TMA-DPH and nystatin
partition coefﬁcient, Kp, in sterol-containing POPC LUV
Mol percent
ergosterol
Mol percent
cholesterol
Total mol
percent sterol
Æræ
6 0.02 Kp (6 0.60 3 10
4)
2.5 2.5 5 0.21 –
5 5 10 – 1.58
7.5 2.5 10 – 1.45
7.5 7.5 15 0.21 –
7.5 22.5 30 0.23 1.59
10 5 15 0.21 1.05
10 10 20 0.20 –
15 – 15 0.21 –
20 – 20 0.21 1.67
20 5 25 0.22 1.52
20 10 30 0.22 –
30 – 30 0.22 1.40
– 20 20 – 1.42
– 30 30 0.22 1.31
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formation of Nys-Chol aggregates in lipid membranes by a
competition displacement assay. To this end, we have carried
out time-resolved ﬂuorescence measurements of Nys in the
presence of ternary Erg/Chol/POPC lipid vesicles where
both the total sterol content and Erg/Chol molar ratios was
varied. The mean ﬂuorescence lifetime of this polyene
antibiotic has already proven to be a good reporter of Nys
complexation with Erg in lipid bilayers (5). Our data show
that the long-lived ﬂuorescent antibiotic species, ascribed to
the assembly of very rigid and compact Erg-antibiotic com-
plexes in the lipid vesicles, progressively disappeared as the
Chol concentration in the ternary lipidmixtureswas increased,
either by keeping constant the total sterol content (Fig. 1) or
the Erg mol fraction (Fig. 2). Moreover, permeabilization
studies showed that Nys was able to completely dissipate
the K1 gradient in all type of vesicles, thus conﬁrming the
formation of antibiotic active species independently of sterol
composition. However, the initial rate of pore formation was
dependent on the Erg/Chol molar ratio. Increasing Erg
relatively to Chol sharply increased the initial rate of pore
formation. In the ternary lipid vesicles, the presence of Erg
always led to an initial gradient rate of dissipation higher as
compared to the binary Chol/POPC vesicles, whereas small
amounts of Chol had the opposite effect when compared to
Erg/POPC vesicles.
It has been previously hypothesized that sterols may affect
polyene antibiotics mode of action by two distinct mecha-
nisms,which are notmutually exclusive: either through changes
of the bulk physical properties of the lipid bilayer after mod-
iﬁcations of its sterol content and/or via the establishment of
speciﬁc antibiotic-sterol interactions. Discrimination between
these two possibilities therefore requires characterization
of the inﬂuence of sterols on membrane bilayer structural
properties and on polyene antibiotics self-association. The
eventual contribution of the ﬁrst hypothesis to explain our
time-resolved ﬂuorescence data was ruled out because the
partitioning behavior of Nys was not affected by the variable
lipid composition (Erg/Chol/POPC ternary mixtures) used in
the preparation of the LUV. Moreover, the steady-state
ﬂuorescence emission anisotropy of TMA-DPH failed to
report any signiﬁcant changes in the interfacial properties of
these lipid vesicles upon varying their sterol content and
composition. Also, the partial phase diagrams of Erg/ and
Chol/POPC binary lipid mixtures were shown to be very
similar (Fig. 4 B), only the ﬁrst presenting a narrower ld1 lo
phase coexistence region as compared to the second one.
Recently, Hsueh et al. (21) using deuterium nuclear magnetic
resonance and differential scanning calorimetry studies have
also shown that lo domains exist in liquid crystalline mem-
branes containing Erg. Previous studies had already empha-
sized the comparable ability of Chol and Erg in inducing a
more ordered packing of the phospholipid acyl chains in
bilayers of phosphatidylcholines/sterol at high sterol content
(22,23).
From the above, we conclude that the time-resolved ﬂuo-
rescence experiments and activity studies carried out in this
study strongly support the view that Chol is competing with
Erg for Nys binding in the membranes. Two nonmutually
exclusive interpretations of the above data are possible: either
Nys forms solely binary complexes with each type of sterol,
or Erg can be progressively exchanged with Chol resulting
in the formation of mixed ternary antibiotic-Erg-Chol com-
plexes with probable variable antibiotic:Erg:Chol stoichi-
ometries and aggregation numbers. In both cases, it is
expected that the progressive displacement of Erg by Chol
must induce a structural rearrangement in the aggregates,
causing a decrease in the overall rigidity experienced by the
polyene chains of Nys, and therefore abolishing their typical
long mean ﬂuorescence lifetime. Interestingly, Thewalt and
co-workers (21) showed that in the presence of Erg the chain
conformational freedom of 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) is lower when compared to the
effect of Chol. Also, Urbina et al. (23) have shown that 30
mol % Erg orders the acyl chains of dimyristoylphosphati-
dylcholine more strongly than Chol. Thus, is also likely that
Nys aggregates experience a higher rigidity in the presence
of Erg. It should be stressed that excitonic coupling and
formation of long-lived oligomers can only be explained by
an increase in the packing that brings close together with a
parallel orientation the transition moments of the chromo-
phores (5). The differences observed for the initial rate of pore
formation can be explained by the formation of channels
with similar conductances but different lifetimes, as shown
by Brutyan and McPhie (24). The stability of the channels is
also a key element in the rate of permeabilization. Molecular
modeling studies with AmB (25) have shown that the
antibiotic channels were more stable in the presence of Erg-
containing as compared to Chol-containing membranes. It is
then possible that Erg increases the stability of Nys channels
by increasing the rigidity of the aggregate structure.
Due to the complexity of the system studied, and lack of
information about the homogeneity and stoichiometries of
the simpler Nys-Erg and Nys-Chol binary complexes, dis-
sociation constants for Nys-sterol interactions could not be
calculated from the above data, preventing an evaluation of
Nys-sterol afﬁnities. Eventually, the performance of single-
channel recording experiments with Nys might help to
characterize the properties of the putative mixed Erg-Chol-
antibiotic species formed in similar ternary lipid mixtures, like
Brutyan and McPhie (24) and Matsumori et al. (26) did with
AmB and AmB-sterol covalent conjugates, respectively.
CONCLUSIONS
In summary, our results show that Chol has the ability to
abolish the formation of strongly ﬂuorescent Nys-Erg
complexes in sterol-containing POPC LUV. This effect
stems from a direct competition between these two sterols for
Nys binding, indirectly conﬁrming Chol’s ability to coassembly
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with the antibiotic, and does not result from a change in the
membrane structural properties due to a variation of their
overall sterol content or the Erg/Chol molar ratio. To our
knowledge this is the ﬁrst study clearly showing a direct
interaction between Nys and Chol. These results are relevant
in the context of the characterization of the distinct steps
involved in Nys mode of action at the molecular level, and
emphasize the different spectroscopic properties presented
by the mixed Nys-Chol and Nys-Erg assemblies formed in
the lipid bilayers, giving insight to their distinct molecular
architectures.
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